A three-hospital system in Oswego, N.Y., filled its pharmacy director position with Sarah Driscoll, PharmD, who has been in the role in an interim capacity since June. 

Sen. Bernie Sanders, I-Vt., is urging HHS to investigate the National Institutes of Health's proposal to grant an exclusive patent to a cancer drug that NIH invented, manufactured and tested. 

Lexington, Ky.-based Appalachian Regional Healthcare has promoted Colby Newsome, PharmD, to director of its Behavioral Health Pharmacy.

Since launching in 2018, hospital-owned Civica Rx works with about a third of the nation's hospitals and manufactures 80 drugs facing shortages, NBC affiliate KSL-TV reported Oct. 22. 

The FDA is reviewing a nasal spray that could be the first self-administered flu vaccine if approved.

As the U.S. anticipates an increase in knee and hip replacement surgeries, adding a second antibiotic does not help prevent postoperative infections and can even spur adverse events, according to a recent study.

Pharmacies are disappearing across the country as retail chains cull hundreds of locations, and the closures are disproportionately affecting vulnerable populations, The Washington Post reported Oct. 22.

The FDA granted full-approval to Pfizer's meningococcal disease immunization, Penbraya, on Oct. 20. 

Mark Cuban's Cost Plus Drug. Co. is teaming up with Birmingham (Ala.) Apothecary to offer Team Cuban Cards beginning Nov. 1, Bham Now reported Oct. 20. 

Roche has agreed to acquire Telavant Holdings — the maker of an inflammatory bowel disease drug — from Roivant Sciences and Pfizer for $7.25 billion, the Switzerland-based company said in an Oct. 23 news release.